Journal of the Japan Diabetes Society
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Volume 48, Issue 5
Displaying 1-7 of 7 articles from this issue
Original Article
  • Kazuko Kanda, Yosuke Okada, Emiko Morita, Hidekatsu Sugimoto, Yoshiya ...
    2005 Volume 48 Issue 5 Pages 309-315
    Published: 2005
    Released on J-STAGE: April 11, 2008
    JOURNAL FREE ACCESS
    Objective : To define the life style of diabetic patients especially those in the work force and to study the problems related to treatment of diabetes in patients who require treatment during working hours.
    Research design and method : The study subjects were 698 outpatients of our diabetes mellitus clinic. A questionnaire on the life style, work and home conditions and treatment modalities, was sent to these patients.
    Results : (1) The mean HbA1c level of 317 working diabetic patients (7.2±1.7%) was significantly higher than that of 381 non-working diabetic patients (6.7±1.2%). (2) The proportion of alcohol drinkers and smokers was higher while the proportion of those taking regular exercise was lower in the working patients than in the non-working patients. (3) Importantly, any medication including insulin injections is needed during working hours in 22.8% of the working patients, 26.4% of whom sometimes fail to take their medications as well as insulin injections.
    Conclusions : Blood glucose control of working patients may be worse than that of non-working patients, and some patients may fail to take their medications including insulin injections while at work. These alarming results emphasize the need for special programs to educate patients and their employers on the need for strict adherence to treatment of diabetes mellitus.
    Download PDF (523K)
  • So Nagai, Satoshi Taniguchi, Masaaki Umetsu, Shinya Mishima, Tatsujiro ...
    2005 Volume 48 Issue 5 Pages 317-323
    Published: 2005
    Released on J-STAGE: April 11, 2008
    JOURNAL FREE ACCESS
    Octreotide therapy has proved effective in treating acromegaly. In these patients, a high incidence of impaired glucose tolerance is recognized. Octreotide acetate decreases growth hormone in over 90% of acromegalic patients, but glucose tolerance is not always improved. We studied the long-term effects of octreotide acetate on glucose metabolism among acromegalic patients. AUC glucose and AUC IRI calculated on 75 g OGTT, insulin sensitivity and β-cell function evaluated by HOMA-S and -β, HbA1c, GH, and IGF-I were assessed in patients eligible for evaluation before and after octreotide therapy. GH and IGF-I decreased significantly with octreotide therapy (p<0.01). HbA1c worsened significantly after octreotide treatment in diabetic patients diagnosed before octreotide therapy (p<0.05). HOMA-S was unchanged. HOMA-β was significantly reduced (p<0.05) after octreotide therapy. In conclusion, octreotide therapy for acromegalic patients with diabetes mellitus requires careful monitoring of glucose tolerance.
    Download PDF (245K)
Case Report
Co-medical
feedback
Top